G61532BD
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38339036 | Saturation Transfer Difference NMR and Molecular Docking Interaction Study of Aralkyl-Thiodigalactosides as Potential Inhibitors of the Human-Galectin-3 Protein | Hőgye F | 2024 Feb 01 |
|
| 38394919 | Glycomimetic inhibitors of tandem-repeat galectins: Simple and efficient | Vrbata D | 2024 Apr |
|
| 34837848 | Synthesis of fluorinated thiodigalactoside analogues | St-Gelais J | 2022 Jan |
|
| 35157467 | Glycopolymers Decorated with 3-O-Substituted Thiodigalactosides as Potent Multivalent Inhibitors of Galectin-3 | Vrbata D | 2022 Feb 14 |
|
| 35427125 | Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia | Bum-Erdene K | 2022 Apr 15 |
|
| 32380514 | Diversity in kinetics correlated with structure in nano body-stabilized LacY | Kumar H | 2020 May 07 |
|
| 32368810 | Regioselective 3‐O‐Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors | Vašíček T | 2020 Jul 08 |
|
| 29382172 | Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions | Chan YC | 2018 Jan 29 |
|
| 29284090 | Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity | Peterson K | 2018 Jan 11 |
|
| 29320431 | Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives | Wdowiak K | 2018 Jan 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026